Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$3.03B |
 |
Anavex Life SciencesAVXL |
$18,000 |
 |
AmgenAMGN |
-$168M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Napolitano Janet | Jun 1, 2026 | Sell | 3,200 | $9.45 | $30,000 |
| Sabatini Brent | Jun 1, 2026 | Sell | 379 | $9.45 | $3,600 |
| SATO VICKI L | May 1, 2026 | Sell | 22,000 | $10.0466 | $220,000 |
| De Backer Marianne | Apr 6, 2026 | Sell | 72,559 | $9.156 | $660,000 |
| SATO VICKI L | Apr 1, 2026 | Sell | 22,000 | $9.0735 | $200,000 |
| Sabatini Brent | Mar 23, 2026 | Sell | 7,711 | $9.12 | $70,000 |
| SATO VICKI L | Mar 2, 2026 | Sell | 21,800 | $9.5039 | $210,000 |
| SATO VICKI L | Mar 2, 2026 | Sell | 200 | $9.98 | $2,000 |
| de Verneuil Vanina | Feb 25, 2026 | Sell | 13,700 | $9.82 | $130,000 |
| Eisner Mark | Feb 25, 2026 | Sell | 1,889 | $9.82 | $19,000 |
| SATO VICKI L | Feb 24, 2026 | Sell | 42,177 | $9.7521 | $410,000 |
| De Backer Marianne | Feb 24, 2026 | Sell | 14,762 | $9.5326 | $140,000 |
| Sabatini Brent | Feb 24, 2026 | Sell | 1,430 | $9.5326 | $14,000 |
| O'Byrne Jason | Feb 24, 2026 | Sell | 1,634 | $9.5326 | $16,000 |
| Eisner Mark | Feb 24, 2026 | Sell | 1,616 | $9.5326 | $15,000 |
| de Verneuil Vanina | Feb 24, 2026 | Sell | 3,117 | $9.5326 | $30,000 |
| SATO VICKI L | Feb 24, 2026 | Sell | 200 | $10.26 | $2,100 |
| De Backer Marianne | Feb 23, 2026 | Sell | 19,039 | $7.4528 | $140,000 |
| Sabatini Brent | Feb 23, 2026 | Sell | 1,829 | $7.4528 | $14,000 |
| O'Byrne Jason | Feb 23, 2026 | Sell | 2,089 | $7.4528 | $16,000 |
| Eisner Mark | Feb 23, 2026 | Sell | 2,089 | $7.4528 | $16,000 |
| de Verneuil Vanina | Feb 23, 2026 | Sell | 4,445 | $7.4528 | $33,000 |
| Sabatini Brent | Feb 13, 2026 | Sell | 1,530 | $7.79 | $12,000 |
| SATO VICKI L | Feb 2, 2026 | Sell | 22,000 | $7.7123 | $170,000 |
| SATO VICKI L | Jan 2, 2026 | Sell | 22,000 | $5.9265 | $130,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Dec 1, 2025 | Sell | 191,854 | $5.9826 | $1.1M |
| SATO VICKI L | Dec 1, 2025 | Sell | 22,000 | $6.0032 | $130,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Nov 28, 2025 | Sell | 61,493 | $6.44 | $400,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Nov 26, 2025 | Sell | 127,938 | $6.391 | $820,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Nov 25, 2025 | Sell | 235,971 | $6.38 | $1.5M |
| SB INVESTMENT ADVISERS (UK) LTD | Nov 24, 2025 | Sell | 227,803 | $6.1491 | $1.4M |
| O'Byrne Jason | Nov 17, 2025 | Sell | 6,799 | $5.557 | $38,000 |
| de Verneuil Vanina | Nov 5, 2025 | Sell | 2,385 | $5.16 | $12,000 |
| SATO VICKI L | Nov 3, 2025 | Sell | 22,000 | $5.6385 | $120,000 |
| de Verneuil Vanina | Nov 3, 2025 | Sell | 1,365 | $5.863 | $8,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 29, 2025 | Sell | 100 | $6.49 | $650 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 28, 2025 | Sell | 24,453 | $6.5025 | $160,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 27, 2025 | Sell | 66,403 | $6.0477 | $400,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 24, 2025 | Sell | 46,696 | $5.9595 | $280,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 23, 2025 | Sell | 154,383 | $5.9898 | $920,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 22, 2025 | Sell | 144,266 | $6.1529 | $890,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 21, 2025 | Sell | 109,675 | $6.3002 | $690,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 20, 2025 | Sell | 220,535 | $6.1998 | $1.4M |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 16, 2025 | Sell | 12,844 | $6.1014 | $78,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 15, 2025 | Sell | 16,671 | $6.0702 | $100,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 10, 2025 | Sell | 2,300 | $6.0752 | $14,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 9, 2025 | Sell | 249,060 | $6.1428 | $1.5M |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 8, 2025 | Sell | 466,242 | $6.0479 | $2.8M |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 7, 2025 | Sell | 72,133 | $5.6029 | $400,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 6, 2025 | Sell | 73,955 | $5.6878 | $420,000 |
| SB INVESTMENT ADVISERS (UK) LTD | Oct 3, 2025 | Sell | 450,342 | $5.5553 | $2.5M |
| SATO VICKI L | Oct 1, 2025 | Sell | 22,000 | $5.8362 | $130,000 |
| SATO VICKI L | Sep 2, 2025 | Sell | 22,000 | $4.9914 | $110,000 |
| SATO VICKI L | Aug 1, 2025 | Sell | 22,000 | $4.9863 | $110,000 |
| Eisner Mark | Jul 17, 2025 | Sell | 3,586 | $5.4738 | $20,000 |
| Eisner Mark | Jul 15, 2025 | Sell | 6,796 | $5.4682 | $37,000 |
| SATO VICKI L | Jul 1, 2025 | Sell | 22,000 | $5.1003 | $110,000 |
| Napolitano Janet | Jun 2, 2025 | Sell | 3,200 | $5.0465 | $16,000 |
| De Backer Marianne | Apr 3, 2025 | Sell | 79,712 | $5.9494 | $470,000 |
| de Verneuil Vanina | Feb 26, 2025 | Sell | 7,373 | $9.1418 | $67,000 |
| SCANGOS GEORGE A | Feb 24, 2025 | Sell | 10,056 | $9.4534 | $95,000 |
| HANLY ANN M. | Feb 24, 2025 | Sell | 14,168 | $9.4534 | $130,000 |
| De Backer Marianne | Feb 24, 2025 | Sell | 16,122 | $9.4534 | $150,000 |
| Sabatini Brent | Feb 24, 2025 | Sell | 1,562 | $9.4534 | $15,000 |
| de Verneuil Vanina | Feb 24, 2025 | Sell | 5,140 | $9.4534 | $49,000 |
| SCANGOS GEORGE A | Feb 18, 2025 | Sell | 10,964 | $9.8117 | $110,000 |
| Sabatini Brent | Feb 13, 2025 | Sell | 1,562 | $9.1494 | $14,000 |
| SATO VICKI L | Jan 8, 2025 | Sell | 10,960 | $12.52 | $140,000 |
| de Verneuil Vanina | Dec 2, 2024 | Sell | 76 | $8.2201 | $620 |
| de Verneuil Vanina | Nov 6, 2024 | Sell | 4,397 | $10.11 | $44,000 |
| de Verneuil Vanina | Nov 5, 2024 | Sell | 2,347 | $9.4696 | $22,000 |
| de Verneuil Vanina | Nov 1, 2024 | Sell | 1,403 | $7.2039 | $10,000 |
| Napolitano Janet | Sep 9, 2024 | Sell | 12,190 | $7.7959 | $95,000 |
| Ramasastry Saira | Jun 11, 2024 | Sell | 4,000 | $10.9473 | $44,000 |
FAQ - Insider Transactions
The most recent insider transaction for Vir Biotechnology was conducted by Napolitano Janet, who sold 3,200 shares on June 1, 2026 at a price of $9.45 per share.
SB INVESTMENT ADVISERS (UK) LTD has sold the most VIR stock in the last 2 years, with a total value of $18M.
The total value of insider transactions for Vir Biotechnology in the last 2 years is negative, amounting to -$23M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Vir Biotechnology have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
